Cargando…
Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro
Dendrimers as drug carriers can be utilized for drugs and siRNA delivery in central nervous system (CNS) disorders, including various types of cancers, such as neuroblastomas and gliomas. They have also been considered as drugs per se, for example as anti-Alzheimer’s disease (AD), anti-cancer, anti-...
Autores principales: | Szwed, Aleksandra, Miłowska, Katarzyna, Michlewska, Sylwia, Moreno, Silvia, Shcharbin, Dzmitry, Gomez-Ramirez, Rafael, de la Mata, Francisco Javier, Majoral, Jean-Pierre, Bryszewska, Maria, Gabryelak, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175207/ https://www.ncbi.nlm.nih.gov/pubmed/32182909 http://dx.doi.org/10.3390/biom10030427 |
Ejemplares similares
-
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells
por: Michlewska, Sylwia, et al.
Publicado: (2020) -
Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line
por: Lazniewska, Joanna, et al.
Publicado: (2013) -
Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug
por: Michlewska, Sylwia, et al.
Publicado: (2019) -
Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics
por: Mignani, Serge, et al.
Publicado: (2022) -
Interaction of Cationic Carbosilane Dendrimers and Their siRNA Complexes with MCF-7 Cells
por: Białkowska, Kamila, et al.
Publicado: (2021)